Results 101 to 110 of about 1,894 (158)

Transcriptomic Analysis in a Model of Aniridia-Associated Keratopathy for Target Discovery and Evaluation of Duloxetine Therapy. [PDF]

Invest Ophthalmol Vis Sci
Javidjam D, Moustardas P, Dashti A, Aberdam D, Schweitzer-Chaput A, Cisternino S, Bremond-Gignac D, Lagali N.   +7 more
europepmc   +1 more source

Comparison of Duloxetine Supplemented With Pregabalin and Amitriptyline Supplemented With Pregabalin for the Treatment of Postherpetic Neuralgia: A Double-Blind, Randomized Crossover Trial. [PDF]

CNS Neurosci Ther
Wang Y, Wu C, Liu Y, Lou Y, Chen C, Chen Q, Li X, Ma C, Li J, Huang Y.   +9 more
europepmc   +1 more source

Evaluating efficacy of pregabalin in diabetic peripheral neuropathy pain management. [PDF]

Korean J Pain
Joseph T, Modi K, Genkin M, Genkin A, Shah R, Markel L.   +5 more
europepmc   +1 more source

Comparative cohort study of pregabalin nortriptyline and pregabalin duloxetine in the management of diabetic peripheral neuropathic pain. [PDF]

Sci Rep
Dasari PC, Chandu A, Bodala M, Bandaru SP, Chundu UC, Nelluri PS, Thiriveedhi S, Bhatti C, Maharjan S.   +8 more
europepmc   +1 more source

Duloxetine: The Next Gold Standard for Treating Depression and Motor Symptoms in Parkinson's Disease? [PDF]

Actas Esp Psiquiatr
Nogueira GN.
europepmc   +1 more source

Cost-Effectiveness of Pregabalin, Duloxetine, and Milnacipran vs Amitriptyline for Moderate to Severe Fibromyalgia.

JAMA Netw Open
Downen SS, Farag HM, Davies A, Okeke CM, Ben-Umeh KC, Yunusa I, Eguale T.   +6 more
europepmc   +1 more source

Effects of celecoxib combined with duloxetine on chronic pain, depression, and anxiety in patients with knee osteoarthritis. [PDF]

World J Psychiatry
Liu X, Fang Q, Sun YD, Liu N, Liang HH, Li L.   +5 more
europepmc   +1 more source

Prescription Trends and Clinical Decision-Making in Neuropathic Pain Pharmacological Treatment: Results From a Cross-Sectional Survey by the Spanish Pain Society. [PDF]

Eur J Pain
Huerta MÁ, Mayo-Moldes M, Garcia MM, García-Parra B, Matute M, López-Tofiño Y, Paniagua N, Hernández-Secorún M, Soler D, Salmerón M, Taylor J, Verdú E, Valencia JA, Pico S, Díaz-Alejo C, Katsuki M, Serrano-Afonso A, Ruiz-Cantero MC.   +17 more
europepmc   +1 more source

Protective effects of antidepressants against ulcerogenic agents: insights from nonclinical studies. [PDF]

Inflammopharmacology
Stringari C, Stringari H, de Queiroz E Silva TF, Willrich CH, da Silva LM.   +4 more
europepmc   +1 more source

A longitudinal PET study on changes in brain norepinephrine transporter availability following duloxetine treatment in major depressive disorder. [PDF]

Int J Neuropsychopharmacol
Moriguchi S, Takahata K, Takano H, Endo H, Tagai K, Kitamura S, Uchida H, Mimura M, Kubota M, Zhang MR, Higuchi M.   +10 more
europepmc   +1 more source